Numbers were basically what I was expecting. Product sales should be extraordinary in 4th quarter as just began shipping very late September with bulk coming in 4th quarter. Biolock shipments just recently started with more to hopefully hear about in the coming weeks. Biovault shipped later than expected and at this point expecting excellent numbers from Biovault sales in 4th quarter as well.
Cash was obviously low although warrant conversions we discussed a few weeks ago should have eliminated those concerns.
If you look at the 10Q and read the interview today it should give you some perspective on last quarter and the direction SQUM is now going.
The financials in 4th quarter should tell a story.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.